1
|
Fischer D, Weigand MA, Moss R, Veiras S, Kübel B, Garcia-Erce JA, Zacharowski K, Meybohm P, Waters JH, Raasveld SJ, Vlaar APJ, Richards T, Meier J, Lasocki S, Hofmann A, Shander A, von Heymann C, Dietrich G, Fries D, Steinbicker AU, Rondinelli MB, Levy JH, Beck G, Frietsch T. Incorporating the concept of overtransfusion into hemovigilance monitoring: An expert-based definition and criteria from the International HIT-OVER Forum. Transfusion 2025; 65:110-121. [PMID: 39654078 DOI: 10.1111/trf.17973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Revised: 07/09/2024] [Accepted: 07/12/2024] [Indexed: 01/22/2025]
Abstract
BACKGROUND Liberal or overtransfusion (OT) may be regarded as "inappropriate," but it is not reported as a transfusion-related adverse event. A definition of OT is lacking. OT may include overdosing of components, giving the incorrect component, or unnecessary administration without evidence of need for transfusion. OT can be associated with hypercoagulability, thrombosis, alloimmunization, increased mortality, longer hospital stay, increased infection rates, and adverse cardiocirculatory events. STUDY DESIGN AND METHODS In 2023, an expert panel formed a hemovigilance international taskforce embedded in the German Interdisciplinary Taskforce for Clinical Hemotherapy (IAKH). The group was charged with proposing simple criteria to be used by hemovigilance systems to document instances of OT. RESULTS This international initiative combined a narrative review of the literature for the rate and outcomes of OT with transfusion error reports to propose a definition for OT, including a definition for transfusion-induced hypercoagulopathy (TIH), three new codes for OT/TIH and subcodes A to G, three severity categories (serious adverse event, adverse event, near miss), and four incident codes (definite, probable, possible, not determinable). These codes can be used by hemovigilance systems to appropriately document instances of OT. CONCLUSIONS Global adoption of these codes within hemovigilance systems would assist with the recognition and reporting of instances of OT, promote effective policies for adequate clinical administration techniques, and support technical guidelines for avoidance of OT. Thereby, incorporation of OT into hemovigilance strategies could support adequate use of blood products, increase patient safety, and facilitate blood supply and availability.
Collapse
Affiliation(s)
- D Fischer
- German Interdisciplinary Task Force for Clinical Hemotherapy (IAKH), Mannheim, Germany
- Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Ruprechts-Karls-University Heidelberg, Heidelberg, Germany
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
| | - M A Weigand
- Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Ruprechts-Karls-University Heidelberg, Heidelberg, Germany
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
| | - R Moss
- Imperial College Healthcare NHS Trust, London, UK
| | - S Veiras
- Department of Anaesthesiology and Postoperative Critical Care. University Hospital fo Santiago de Compostela, Spain, Department of Surgery and Medical-Surgical Specialties, Santiago de Compostella, Spain
| | - B Kübel
- German Interdisciplinary Task Force for Clinical Hemotherapy (IAKH), Mannheim, Germany
| | - J A Garcia-Erce
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- Banco de Sangre y Tejidos de Navarra, Servicio Navarro de Salud, Navarra, Spain
| | - K Zacharowski
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
- Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt am Main, Frankfurt, Germany
- German PBM Network, Germany
- Foundation for Health, Patient Safety, and Patient Blood Management, Germany
| | - P Meybohm
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
- German PBM Network, Germany
- Foundation for Health, Patient Safety, and Patient Blood Management, Germany
- University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg, Germany
| | - J H Waters
- Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
| | - S J Raasveld
- Laboratory of Experimental Intensive Care and Anesthesiology, L.E.I.C.A., Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - A P J Vlaar
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- Laboratory of Experimental Intensive Care and Anesthesiology, L.E.I.C.A., Amsterdam University Medical Center, Amsterdam, The Netherlands
- Department of Intensive Care, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - T Richards
- School of Health, Sport & Bioscience University of East London, London, UK
| | - J Meier
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- Clinic of Anesthesiology and Surgical Intensive Care Medicine, Kepler University Clinic, Kepler University, Linz, Austria
| | - S Lasocki
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- Service, Département d'Anesthésie Réanimation, Pole ASUR-BO, CHU Angers, Angers, France
| | - A Hofmann
- UWA Medical School, Surgery, University of Western Australia, Perth, Australia
| | - A Shander
- Department of Anesthesiology and Critical Care, Team Health, Englewood Health, University of Vermont College of Medicine, Englewood Hospital, Englewood, New Jersey, USA
| | - C von Heymann
- German Interdisciplinary Task Force for Clinical Hemotherapy (IAKH), Mannheim, Germany
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
- Arbeitsausschuss Bluttransfusion von BDA und DGAI, Berlin, Germany
- Department of Anaesthesia, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Vivantes Klinikum im Friedrichshain, Berlin, Germany
| | - G Dietrich
- German Interdisciplinary Task Force for Clinical Hemotherapy (IAKH), Mannheim, Germany
- Arbeitsausschuss Bluttransfusion von BDA und DGAI, Berlin, Germany
- Anesthesia, Intensive Care, Pain Therapy, Transfusion Medicine, Rottal-Inn Kliniken KU, Eggenfelden, Germany
| | - D Fries
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
- Trauma Critical Care, Medical University, Innsbruck, Austria
| | - A U Steinbicker
- German Interdisciplinary Task Force for Clinical Hemotherapy (IAKH), Mannheim, Germany
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
- Faculty of Medicine and University Hospital of Cologne, Department of Anesthesiology and Intensive Care Medicine, University of Cologne, Cologne, Germany
| | - M B Rondinelli
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- Department of Transfusion Medicine, AUSL, Bologna, Italy
| | - J H Levy
- Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina, USA
| | - G Beck
- Clinic for Anesthesiology, Critical Care and Pain Medicine, University Medicine of Mannheim, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany
| | - T Frietsch
- German Interdisciplinary Task Force for Clinical Hemotherapy (IAKH), Mannheim, Germany
- Network of Advanced Patient Blood Management, Haemostasis and Thrombosis (NATA), Munich, Germany
- German Interdisciplinary Association for Critical Care and Emergency Medicine (DIVI), Section Hemotherapy and Hemostaseology, Hamburg, Germany
- Arbeitsausschuss Bluttransfusion von BDA und DGAI, Berlin, Germany
- Clinic for Anesthesiology, Critical Care and Pain Medicine, University Medicine of Mannheim, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany
| |
Collapse
|